This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
worried that if they asked too many questions, their doctor would see them as a difficult patient, which would affect the quality of care they received†3
of patients often regretted not telling their doctor more during consultations†3
of patients wished they talked more about their fears of medical treatments with their doctor†3
Perception of burden of disease:
Doctors ranked diarrhoea (bloody) as the top UC symptom to impact a patient's quality of life, whereas patients most commonly rated rectal urgency as having the greatest impact**††4
Quality of life related treatment goals:
Doctors ranked increasing the patients ability to work/attend school as the top treatment goal related to quality of life, whereas patients prioritised improved emotional mood**††4
In a survey, 30% of patients with UC rated the impact of UC on their mental wellbeing as an aspect that they wished their doctor had a better understanding of.‡‡5
However, only 23% of doctors reported regularly discussing this topic with their patients‡‡5
Xeljanz®(tofacitinib citrate) Prescribing information and Inflectra®(infliximab) Prescribing information.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024